Antimutagenicity profiles for some model compounds

Mutation Research/Reviews in Genetic Toxicology

Volumn 238, Issue 1, 1990, Pages 57-85

  Waters, Michael D ^a   Brady, Ann L ^b   Stack, H Frank ^b   Brockman, Herman E ^c  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b Environmental Health Research and Testing Inc ^*  (United States)

^c ILLINOIS STATE UNIVERSITY   (United States)

Author keywords

Activity profile listings; Antimutagenicity profiles; Model compounds; plots

Indexed keywords

AFLATOXIN B1; ANTIMUTAGENIC AGENT; BENZO[A]PYRENE; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; DISULFIRAM; GLUTATHIONE; METHYLNITRONITROSOGUANIDINE;

ANIMAL CELL; CELL CULTURE; HAMSTER; HEREDITY; HUMAN; HUMAN CELL; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

BIOTRANSFORMATION; CARCINOGENS; MUTAGENICITY TESTS; MUTAGENS; SALMONELLA TYPHIMURIUM;

EID: 0025173798     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1110(90)90039-E     Document Type: Review

References (136)

1. Identifying environmental chemicals causing mutations and cancer
2. Dietary carcinogens and anticarcinogens
3. Overview: Food constituents as a source of mutagens, carcinogens and anticarcinogens
4. Inhibitory effect of hemin on the mutagenic activities of carcinogens
5. Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems
6. Antimutagenic effects of 2(3)-tert.-butyl-4-hydroxyanisole and of antimicrobial agents
7. Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo[a]pyrene by dietary antioxidants
8. Elevation of extrahepatic glutathione S-transferase and epoxide hydratase activities by 2(3)-tert.-butyl-4-hydroxyanisole
9. Increases of NAD(P)H: quinone reductase by dietary antioxidants: Possible role in protection against carcinogenicity and toxicity
10. 1 in vitro
11. 1: In vitro effect of vitamins
12. Inhibition of macromolecular binding of benzo[a]pyrene and inhibition of neoplasia by disulfiram in the mouse forestomach
13. Investigations on DNA binding in rat liver and in Salmonella and on mutagenicity in the Ames test by emodin a natural antraquinone
14. Utility of short-term tests for genetic toxicity in the aftermath of the NTP's analysis of 73 chemicals
15. 1
16. Screening of antioxidants and other compounds for antimutagenic properties towards benzo[a]pyrene-induced mutagenicity in strain TA98 of Salmonella typhimurium
17. Effects of 2(3)-tert.-butyl-4-hydroxyanisole administration on the activities of several hepatic microsomal and cytoplasmic enzymes in mice
18. Mechanisms of inhibition of N-methyl-N′-nitro-N-nitrosoguanidine induced mutagen by phenolic compounds
19. Conjugation with glutathione and mercapturic acid excretion
20. The role of glutathione and glutathione-S-transferases in the metabolism of chemical carcinogens and other electrophilic agents
21. Reduction of 2-acetylaminofluorene-induced unscheduled DNA synthesis in human and rat hepatocytes by butylated hydroxytoluene
22. Antimutagenesis in microbial systems
23. The protective action of glutathione on the microbial mutagenicity of the Z- and E-isomers of 1,3-dichloropropene
24. Mechanisms of inhibitors of mutagenesis and carcinogenesis Classification and overview
25. In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens
26. Inhibition of benzo[a]pyrene-trans-7,8-diol metabolism and DNA binding in mouse lung explants by ellagic acid
27. Zur Erzeugung subcutaner Sarkome an Ratten, Carcinogene Wirkung von Hydrazodicarbonsaurebis-(methyl-nitrosamid), N-Nitroso-N-n-butylharnstoff, N-methyl-N-nitroso-nitrosoguanidin und N-nitrosoimidazolidon
28. Naturally occurring anticarcinogenic substances in foodstuffs
29. 1: In vitro effect of trace elements
30. Vitamin C is positive in the DNA-synthesis inhibition and sister-chromatid exchange tests
31. 1 to a reactive derivative toxic to Salmonella typhimurium TA1530
32. Antimutagenic effect of p-aminobenzoic acid on the mutagenicity of N-methyl-N′-nitro-N-nitrosoguanidine in Salmonella typhimurium
33. Different patterns of benzo[a]pyrene metabolism of purified cytochrome P-450 from methylcholanthrene, β-naphthoflavone and phenobarbital treated rats
34. In vitro metabolic conversion of aflatoxins and benzo[a]pyrene nucleic acid-binding metabolites
35. Inhibition by l-ascorbate of bacterial mutagenesis induced by two N-nitroso compounds
36. Mechanisms of inhibition by ascorbate of microbial mutagenesis induced by N-nitroso compounds
37. Pyridine prevents the clastogenicity of benzene but not of benzo[a]pyrene or cyclophosphamide
38. Dietary inhibitors of mutagenesis and carcinogenesis
39. Inhibition of binding of benzo[a]pyrene metabolites to nuclear DNA by glutathione and glutathione S-transferase B
40. Vitamin A compounds and analogs as inhibitors of mixed function oxidases that metabolize carcinogenic polycyclic hydrocarbons and other compounds
41. Metabolism and toxicity of aflatoxins
42. 1 in Chinese hamster V79 cells
43. Inhibition of hepatic mixed-function oxidase activity in vitro and in vivo by various thiono-sulfur-containing compounds
44. Induction of sister-chromatid exchanges by N-nitrosocimetidine in cultured human lymphocytes and its inhibition by chemical compounds
45. Inhibitory effects of selenium on the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives
46. A kinetic approach to polycyclic hydrocarbon activation
47. 1 mutagenesis: Addition of glutathione and glutathione-S-transferase to the Salmonella mutagenicity assay
48. Desmutagens and bio-antimutagens: Their action mechanisms and possible role in the modulation of dose relationships
49. Reduction of N-methyl-N′-nitro-N-nitrosoguanidine induced mutations by cobalt chloride in Escherichia coli
50. Antimutagenic actions of vegetable factor(s) on the mutagenic principle of tryptophan pyrolysate
51. Environmental mutagenesis and plant biology
52. 1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione
53. The effect of substituted phenothiazines on the mutagenicity of benzo[a]pyrene
54. Mutagenicity, comutagenicity, and antimutagenicity of erythrosine (FD and C Red 3), a food dye, in the Ames/Salmonella assay
55. Effects of butylated hydroxyanisole on the metabolism of benzo[a]pyrene by mouse liver microsomes
56. Short-time interval effects of butylated hydroxyanisole on the metabolism of benzo[a]pyrene
57. Methylation of deoxyribonucleic acid in cultured mammalian cells by N-methyl-N′-nitro-N-nitrosoguanidine
58. 1 by hepatic microsomes
59. Possible relevance of O-6 alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides
60. Dosedependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene
61. N-Nitroso compounds and related carcinogens
62. Mutagenicity of isomeric diol-epoxides of benzo[a]pyrene and anthracene[a]pyrene in S. typhimurium TA98 and TA100 and in V79 Chinese hamster cells
63. 1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid
64. A new chemical mutagen for bacteria, 1-methyl-3-nitro-1-nitrosoguanidine
65. Protective effect of diethyldithiocarbamate and carbon disulfide against liver injury induced by various hepatotoxic agents
66. Inhibition of promutagen activation by the antioxidants butylated hydroxyanisole and butylated hydroxytoluene
67. Alpha-tocopherol: Uses in preventing nitrosamine formation
68. Reversible inhibition by retinoids of 3-methyl-cholanthrene-induced neoplastic transformation in C3H/10T1/2 CL8 cells
69. Inhibition of the formation of carcinogenic N-nitroso compounds by ascorbic acid and other compounds
70. Lung protection by a thio-containing antioxidant: N-acetylcysteine
71. Inhibition of carcinogenesis by retinoids
72. Immunochemical study on the contributions of two molecular species of cytochrome P-450 in mutagenesis by selected aminoazo dyes
73. Effects of cysteine and a liver metabolic activation system on the activities of mutagenic pesticides
74. Inhibitors for the mutagenicities of color carcinogens, 1,2-dimethylhydrazine and azoxymethane, in the host-mediated assay
75. In vitro antimutagenicity of curcumin against environmental mutagens
76. Comutagenic action of norharman and harman
77. Some high-performance liquid-chromatographic studies of the metabolism of aflatoxins by rat liver microsomal preparations
78. Effect of dimethylnitrosamine on persistence of methylated guanines in rat liver and kidney DNA
79. Anti-mutagens
80. Sodium arsenite inhibits spontaneous and induced mutations in Escherichia coli
81. Prevention of benzo[a]pyrene-induced mutagenicity by homogenous epoxide hydratase
82. Antimutagenic effects of cinnamaldehyde on chemical mutagenesis in Escherichia coli
83. Analysis of the antimutagenic effect of cinnamaldehyde on chemically induced mutagenesis in Escherichia coli
84. Selenium inhibition of benzo[a]pyrene, 3-methylcholanthrene, and 3-methylcholanthrylene mutagenicity in Salmonella typhimurium strains TA98 and TA100
85. Effect of retinoids on carcinogen-induced mutagenesis in Salmonella tester strains
86. Influence of retinol on carcinogen-induced sister chromatid exchanges and chromosome aberrations in V79 cells
87. The effects of antioxidants on the metabolism and mutagenicity of benzo[a]pyrene in vitro
88. 1-induced mutagenesis in Salmonella typhimurium TA98 and TA100
89. 1: Observation of the formation of epoxide-glutathione conjugate
90. Deployment of short-term assays for the detection of carcinogens; genetic and molecular considerations
91. Deployment of short-term assays for the detection of carcinogens; genetic and molecular considerations
92. Inhibitors of mutagenesis and their relevance to carcinogenesis
93. The mutagenic effect of 1,2-dichloroethane on Salmonella typhimurium, 1. Activation through conjugation with glutathione in vitro
94. Modulation of the cytotoxicity and mutagenicity of benzo[a]pyrene and benzo[a]pyrene 7,8-diol by glutathione and glutathione S-transferases in mammalian cells (CHO/HGPRT assay)
95. Effect of micronutrients, antioxidants and related compounds on the mutagenicity of 3,2-dimethyl-4-aminobiphenyl, a colon and breast carcinogen
96. Inhibitory effect of reducing agents on N-acetoxy- and N-hydroxy-2-acetylaminofluorene-induced mutagenesis
97. The inhibitory effect of cysteine on the mutagenic activities of several carcinogens
98. Assessment of the use of the Salmonella mutagensis assay to determine the influence of antioxidants on carcinogen-induced mutagenesis
99. Enhancing and inhibiting effects of propyl gallate on carcinogen-induced mutagenesis
100. Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene
101. 1 metabolism and induced mutagenesis
102. Desmutagenic effect of humic acid
103. Mechanism of the desmutagenic effect of humic acid
104. Carcinogenic activity of N-methyl-N-nitroso-N′-nitroguanidine
105. Carcinogen-induced chromosomal breakage decreased by antioxidants
106. Antioxidants reduce the mutagenic effect of malonaldehyde and β-propiolactone
107. 1
108. Selective inhibition and kinetics of enzymatic reactions leading to irreversible binding of benzo[a]pyrene to microsomal macromolecules of mouse lung
109. Bio-antimutagenic effects of tannic acid on UV and chemically induced mutagenesis in Escherichia coli B/r
110. Protection by diethyldithiocarbamate, a CS2-liberating agent, against different modes of experimentally-induced liver injury
111. The SCE-inducing capacity of vitamin C: Investigations in vitro and in vivo
112. The response of xeroderma pigmentosum cells and controls to the activated mycotoxins, aflatoxins and sterigmatocystin
113. Naturally occurring phenolics as antimutagenic and anticarcinogenic agents
114. Tumor production in glandular stomach of rat by N-methyl-N′-nitro-N-nitrosoguanidine
115. Carcinogenic action of N-methyl-N′-nitro-N-nitrosoguanidine
116. Tumor production in the glandular stomach and alimentary tract of the rat by N-methyl-N′-nitro-N-nitrosoguanidine
117. Selenium modified mutagenicity and metabolism of benzo[a]pyrene in an S9-dependent system
118. Antimutagenic activity of some naturally occurring compounds towards cigarette-smoke condensate and benzo[a]pyrene in the Salmonella/microsome assay
119. Antimutagenic chalcones: Antagonizing the mutagenicity of benzo[a]pyrene on Salmonella typhimurium
120. Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide in rats
121. Detection of human exposure to electrophilic compounds by assay of thioether detoxification products in urine
122. Use of computerized data listings and activity profiles of genetic and related effects in the review of 195 compounds
123. Inhibition of chemical carcinogenesis
124. Inhibitors of chemical carcinogenesis
125. Inhibition of neoplasia by minor dietary constituents
126. Chemoprevention of cancer
127. Mutagenic and antimutagenic activities of selenium compounds in mammalian cells
128. Presence of cytochrome P-450 and cytochrome P-448-dependent monooxygenase functions in hepatoma cell lines
129. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis
130. Desmutagenic effects of N-acetylcysteine on direct and indirect mutagens
131. Mutagenicity and cytotoxicity of benzo[a]pyrene, arene oxides, phenols, quinones and dihydrodiols in bacterial and mammalian cells
132. High mutagenicity and toxicity of a diol epoxide derived from benzo[a]pyrene
133. Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential
134. Differences in mutagenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides
135. Inhibition of hepatic mixed function oxidase activity by propyl gallate
136. Inhibition of the monooxygenase by BHA and BHT